<DOC>
	<DOC>NCT01104948</DOC>
	<brief_summary>This is a dose block-randomized, double-blind, placebo-controlled, single/multiple dosing, dose-escalation study. The study is designed to describe the relationship between multiple doses and pharmacokinetic parameters of DA-8031 as well as safety profile.</brief_summary>
	<brief_title>A Study to Characterize the Pharmacokinetics of DA-8031 in Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>2045 years healthy male subjects Body weight :6090kg, BMI between 18.525 show SBP(Systolic Blood Pressure) =&lt;100mmHg or &gt;=140mmHg, or DBP(Diastolic Blood Pressure)=&lt;60mmHg or &gt;=90mmHg, or tachycardia (PR(Pulse Rate)&gt;=100times/min) have a history of drug abuse or show positive for drug abuse or cotinine at urine screening smokers</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>